Search - tctmd.com

Displaying 1 - 20 of 143

Sort: Relevancy | Date

News Conference News TCT 2025

DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES

Yael L. Maxwell

November 04, 2025

News Conference News TCT 2025

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

Todd Neale

November 03, 2025

Presentation TCT 2025

TCT 1014: Cost-effectiveness of clopidogrel versus aspirin for chronic maintenance therapy after percutaneous coronary intervention: results from the HOST-EXAM Extended study

Presenter: Jeehoon Kang

October 28, 2025

Presentation TCT 2025

TCT 1008: Aspirin vs. Clopidogrel as Monotherapy for Secondary Prevention in Stable Coronary Artery Disease: An Updated Meta Analysis

Presenter: Timothy Charles Shuey

October 27, 2025

Presentation TCT 2025

TCT 997: Long-Term Clopidogrel vs Aspirin Monotherapy in coronary artery disease patients with High Ischemic Risk: HOST-EXAM Extended Study Post Hoc Analysis

Presenter: Jin-Eun Song

October 27, 2025

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

Presentation TCT 2025

TCT 55: A Meta-Analysis on Safety and Efficacy of P2Y12 Inhibitor Monotherapy versus Aspirin Monotherapy After 12 Months of DAPT in Patients Post Percutaneous Coronary Intervention

Presenter: Asna Aafreen

October 26, 2025

Presentation TCT 2025

TCT 226: Aspirin Versus Clopidogrel Following Transcatheter Aortic Valve Replacement: A TVT Registry Propensity Matched Analysis

Presenter: Yuri Pride

October 25, 2025

Presentation TCT 2025

Clopidogrel Monotherapy Following 1-Month DAPT vs. Aspirin Monotherapy Following 12-Month DAPT After PCI in ACS Patients: Final 5-Year Results of the STOPDAPT-2 ACS Trial

Presenter: Hirotoshi Watanabe

October 25, 2025

Presentation TCT 2025

Aspirin Monotherapy After 1-Month DAPT in High Bleeding Risk Patients Undergoing PCI: The TARGET SAFE Randomized Trial

Presenter: Miaohan Qiu

October 25, 2025

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

News Conference News TCT 2024

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

Yael L. Maxwell

October 29, 2024

News Conference News TCT 2024

LAAO Outcomes Similar Regardless of Operator’s Specialty

Todd Neale

October 27, 2024

Presentation TCT 2024

TCT 231: Safety of Aspirin-Free Prasugrel Monotherapy After PCI: Pooled Analysis of Three Months Outcomes in 508 Patients From ASET-I and ASET-Japan Trials

Presenter: KOTARO MIYASHITA

October 27, 2024

Presentation TCT 2024

TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial

Presenter: Mauro Gitto

October 27, 2024

Presentation TCT 2024

TCT 6: Aspirin-Free Prasugrel Monotherapy After PCI in Patients With Non-ST Elevation Acute Coronary Syndrome

Presenter: KOTARO MIYASHITA

October 27, 2024

Presentation TCT 2024

TCT 2: Less Bleeding by Omitting Aspirin in Non-ST-Segment Elevation Acute Coronary Syndrome Patients (LEGACY)

Presenter: Shabiga Sivanesan

October 27, 2024

Presentation TCT 2024

TCT 237: Long-Term Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease Patients With High Ischemic Risk: A Post Hoc Analysis of the HOST-EXAM Extended Study

Presenter: Jeehoon Kang

October 27, 2024

Presentation TCT 2023

TCT 165: Aspirin-Free Prasugrel Monotherapy: Thirty Days Clinical Outcome after Percutaneous Coronary Intervention in Chronic Coronary Syndrome and Non-ST Segment Elevation Acute Coronary Syndrome

Presenter: Gaku Nakazawa

October 26, 2023

Presentation TCT 2023

TCT 657: Aspirin versus P2Y12 inhibitor as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation (AF).

Presenter: Hyunki LEE

October 25, 2023

Advertisement

DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

TCT 1014: Cost-effectiveness of clopidogrel versus aspirin for chronic maintenance therapy after percutaneous coronary intervention: results from the HOST-EXAM Extended study

TCT 1008: Aspirin vs. Clopidogrel as Monotherapy for Secondary Prevention in Stable Coronary Artery Disease: An Updated Meta Analysis

TCT 997: Long-Term Clopidogrel vs Aspirin Monotherapy in coronary artery disease patients with High Ischemic Risk: HOST-EXAM Extended Study Post Hoc Analysis

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

TCT 55: A Meta-Analysis on Safety and Efficacy of P2Y12 Inhibitor Monotherapy versus Aspirin Monotherapy After 12 Months of DAPT in Patients Post Percutaneous Coronary Intervention

TCT 226: Aspirin Versus Clopidogrel Following Transcatheter Aortic Valve Replacement: A TVT Registry Propensity Matched Analysis

Clopidogrel Monotherapy Following 1-Month DAPT vs. Aspirin Monotherapy Following 12-Month DAPT After PCI in ACS Patients: Final 5-Year Results of the STOPDAPT-2 ACS Trial

Aspirin Monotherapy After 1-Month DAPT in High Bleeding Risk Patients Undergoing PCI: The TARGET SAFE Randomized Trial

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

LAAO Outcomes Similar Regardless of Operator’s Specialty

TCT 231: Safety of Aspirin-Free Prasugrel Monotherapy After PCI: Pooled Analysis of Three Months Outcomes in 508 Patients From ASET-I and ASET-Japan Trials

TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial

TCT 6: Aspirin-Free Prasugrel Monotherapy After PCI in Patients With Non-ST Elevation Acute Coronary Syndrome

TCT 2: Less Bleeding by Omitting Aspirin in Non-ST-Segment Elevation Acute Coronary Syndrome Patients (LEGACY)

TCT 237: Long-Term Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease Patients With High Ischemic Risk: A Post Hoc Analysis of the HOST-EXAM Extended Study

TCT 165: Aspirin-Free Prasugrel Monotherapy: Thirty Days Clinical Outcome after Percutaneous Coronary Intervention in Chronic Coronary Syndrome and Non-ST Segment Elevation Acute Coronary Syndrome

TCT 657: Aspirin versus P2Y12 inhibitor as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation (AF).

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content